|
Market Cap (25-May) $65,067,412 (361st) |
Close (30-Jun) $0.100 |
Volume (30-Jun) 1,754,344 |
Shortsold (29-Nov) 5,010,077 (0.32%) (345th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -1.3 |
IHL released this announcement to the ASX on 22 April 2021, 8:26. The announcement is marked as price sensitive, and is 3 page(s) in length and 186.96kb in size.
You can view all announcements from IHL and see how they appear on a price chart on the announcements page.
At the date of this announcement, IHL was 0.006% short sold according to ASIC data. It was ranked the 595th most shorted stock on the ASX. It is now ranked as the 345th most shorted stock on the ASX with 0.316% of total shares short sold as of the latest reported data (29 November 2023).
| Other Recent Announcements from IHL | |
|---|---|
| Change of Director's Interest Notice | 30 June 2023, 13:57 |
| Change of Registered Office | 26 June 2023, 15:51 |
| IHL Announcement - H.C. Wainwright Virtual Conference | 23 June 2023, 8:17 |
| Positive FDA Pre-IND meeting guides IHL-675A development | 22 April 2021, 8:26 |
| Cleansing Notice and Appendix 2A | 26 March 2021, 15:10 |
| IHL-675A Pre-IND meeting with FDA update | 25 March 2021, 9:06 |
| IHL-675A outperforms existing treatment for arthritis | 16 March 2021, 9:39 |
You must be logged in to post a reply.
Incannex Healthcare 